March 1, 2002

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin‐1 receptor antagonist, in combination with methotrexate: Results of a twenty‐four–week, multicenter, randomized, double‐blind, placebo‐controlled trial

SCStanley CohenTexas Health Dallas EHEric R. HurdUnited States Department of Veterans Affairs JCJohn J. CushTexas Christian University

Key Points

Key points are not available for this paper at this time.

Abstract

In patients with persistently active RA, the combination of anakinra and MTX was safe and well tolerated and provided significantly greater clinical benefit than MTX alone.

KI fragen

Bookmark

View Full Paper

Cite This Study

Cohen et al. (Fri,) studied this question.

synapsesocial.com/papers/69d8c097d2f7327e70ae42a4 https://doi.org/https://doi.org/10.1002/art.10141

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

KI fragen

Bookmark

View Full Paper